Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Warren, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Bellerophon Therapeutics, Inc. has filed 643 SEC EDGAR filings since 21 Feb 2014

SEC filing history

Showing 151-175 of 643 matching filings.

Per page
25
Current page
7
SC 13G/A File 005-88741

SC 13G/A filing

Filing date
12 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
11 Jan 2021
Reporting date
11 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88741

SABBY 13G-A BLPH 1.05.21

Filing date
05 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
01 Dec 2020
Reporting date
01 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
23 Nov 2020
Reporting date
23 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
05 Nov 2020
Reporting date
04 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Sep 2020
Reporting date
10 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Sep 2020
Reporting date
10 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Sep 2020
Reporting date
10 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Sep 2020
Reporting date
10 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Sep 2020
Reporting date
10 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Sep 2020
Reporting date
10 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Sep 2020
Reporting date
10 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Sep 2020
Reporting date
10 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Sep 2020
Reporting date
10 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
11 Sep 2020
Reporting date
10 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
05 Aug 2020
Reporting date
05 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

FORM 8-K

Filing date
17 Jul 2020
Reporting date
17 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-239473

424B5

Filing date
17 Jul 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
13 Jul 2020
Reporting date
13 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-239473

EFFECT filing

Filing date
02 Jul 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
01 Jul 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
01 Jul 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .